chrX-11254716-CAAA-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP6_ModerateBS1
The NM_013427.3(ARHGAP6):c.589-12_589-10delTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 809,472 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., 0 hem., cov: 19)
Exomes 𝑓: 0.011 ( 0 hom. 0 hem. )
Consequence
ARHGAP6
NM_013427.3 intron
NM_013427.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0850
Genes affected
ARHGAP6 (HGNC:676): (Rho GTPase activating protein 6) This gene encodes a member of the rhoGAP family of proteins which play a role in the regulation of actin polymerization at the plasma membrane during several cellular processes. This protein is thought to have two independent functions, one as a GTPase-activating protein with specificity for RhoA, and another as a cytoskeletal protein that promotes actin remodeling. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant X-11254716-CAAA-C is Benign according to our data. Variant chrX-11254716-CAAA-C is described in ClinVar as [Benign]. Clinvar id is 402392.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.0108 (8331/774153) while in subpopulation AMR AF= 0.0285 (272/9534). AF 95% confidence interval is 0.0257. There are 0 homozygotes in gnomad4_exome. There are 0 alleles in male gnomad4_exome subpopulation. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGAP6 | NM_013427.3 | c.589-12_589-10delTTT | intron_variant | ENST00000337414.9 | NP_038286.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGAP6 | ENST00000337414.9 | c.589-12_589-10delTTT | intron_variant | 1 | NM_013427.3 | ENSP00000338967.4 |
Frequencies
GnomAD3 genomes AF: 0.000170 AC: 6AN: 35319Hom.: 0 Cov.: 19 AF XY: 0.00 AC XY: 0AN XY: 5875
GnomAD3 genomes
AF:
AC:
6
AN:
35319
Hom.:
Cov.:
19
AF XY:
AC XY:
0
AN XY:
5875
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0613 AC: 920AN: 15013Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 991
GnomAD3 exomes
AF:
AC:
920
AN:
15013
Hom.:
AF XY:
AC XY:
0
AN XY:
991
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0108 AC: 8331AN: 774153Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 217783
GnomAD4 exome
AF:
AC:
8331
AN:
774153
Hom.:
AF XY:
AC XY:
0
AN XY:
217783
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000170 AC: 6AN: 35319Hom.: 0 Cov.: 19 AF XY: 0.00 AC XY: 0AN XY: 5875
GnomAD4 genome
AF:
AC:
6
AN:
35319
Hom.:
Cov.:
19
AF XY:
AC XY:
0
AN XY:
5875
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at